ClinicalTrials.gov
public full text
Public Domain
A Bioequivalence Study of Tobramycin and Prednisolone Acetate Compared to PredForte
The purpose of this study is to demonstrate the bioequivalence of the combination test agent, prednisolone acetate 1.0% and tobramycin 0.3% ophthalmic suspension compared to PredForte (prednisolone acetate 1.0%) ophthalmic suspension. Bioequivalence will be measured by comparing aqueous humor concentrations of prednisolone acetate.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Triamcinolone Versus Topical Treatment in Post Operative Phacoemulsification#880538
- Efficacy and Safety of Oral Valproic Acid for Retinitis Pigmentosa#885760
- NAION Treatment With Oral Prednisolone and Erythropoietin Injection#1338897
- Study Evaluating a 13-valent Pneumococcal Conjugate Vaccine in Preterm Compared to Term Infants.#1075414
- Phase I Study of Pyrimethamine in Healthy Japanese and Caucasian Subjects#832072
Record · ID 1184161
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive